DAY THREE WATCH LIVE (EST); 21/10/20keyboard_arrow_right
Search keyboard_arrow_right
keyboard_arrow_left Hide
DAY THREE WATCH LIVE (EST); 21/10/20
search
DAY THREE WATCH LIVE (EST); 21/10/20
search
This agenda is just the start. Wherever you are in the world, the Cell Therapy Bioprocessing & Commercialization and Cell Therapy Manufacturing & Gene Therapy Congresses are coming to you. The talks listed here are just the tip of the iceberg. Please also make sure to browse all of our 'on-demand' sessions which available to watch at your convenience.
DAY THREE WATCH LIVE (EST); 21/10/20 7:30am - 7:50am20 mins
Cell Therapy
Analytical Method Development and Validation – Building the Characterization Testing Foundation & Toolkit
- Lara Ionescu Silverman - Senior Director, Research and Development, DiscGenics
DAY THREE WATCH LIVE (EST); 21/10/20 7:30am - 7:50am20 mins
Gene Edited Ex Vivo Cell Therapy
Analytical Method Development and Validation – Building the Characterization Testing Foundation & Toolkit
- Lara Ionescu Silverman - Senior Director, Research and Development, DiscGenics
DAY THREE WATCH LIVE (EST); 21/10/20 7:30am - 7:50am20 mins
In Vivo Gene Therapy
The Case for rAAV Titration by HPLC
- Franz Schnetzinger - Director Analytical Development, Gyroscope Therapeutics
DAY THREE WATCH LIVE (EST); 21/10/20 7:30am - 7:50am20 mins
Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
Developing Your Manufacturing Process from A->Z
- Priya Baraniak - Vice President, Corporate Development, OrganaBio
DAY THREE WATCH LIVE (EST); 21/10/20 7:50am - 8:15am25 mins
Cell Therapy
Speaker Q&A - Cell Therapy Analytics – Testing, Characterization & Validation Strategies
- Steve Oh - Director Stem Cell Bioprocessing & Institute Professor,, Bioprocessing Technology Institute
- Lara Ionescu Silverman - Senior Director, Research and Development, DiscGenics
- Barrett J. Nehila - Associate Director, Analytical Development, Torque Therapeutics
DAY THREE WATCH LIVE (EST); 21/10/20 7:50am - 8:15am25 mins
Gene Edited Ex Vivo Cell Therapy
Speaker Q&A - Cell Therapy Analytics – Testing, Characterization & Validation Strategies
- Steve Oh - Director Stem Cell Bioprocessing & Institute Professor,, Bioprocessing Technology Institute
- Lara Ionescu Silverman - Senior Director, Research and Development, DiscGenics
- Barrett J. Nehila - Associate Director, Analytical Development, Torque Therapeutics
DAY THREE WATCH LIVE (EST); 21/10/20 7:50am - 8:15am25 mins
In Vivo Gene Therapy
Break
DAY THREE WATCH LIVE (EST); 21/10/20 7:50am - 8:10am20 mins
Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
Development of Modular Biofabrication Platforms for Diverse Tissue Engineering Applications
- George Joseph Christ - Professor of Biomedical Engineering and Orthopaedic Surgery, University of Virginia
DAY THREE WATCH LIVE (EST); 21/10/20 8:10am - 9:15am65 mins
Cell Therapy
Coffee Break & Exhibition Viewing Time
DAY THREE WATCH LIVE (EST); 21/10/20 8:10am - 9:15am65 mins
Gene Edited Ex Vivo Cell Therapy
Coffee Break & Exhibition Viewing Time
DAY THREE WATCH LIVE (EST); 21/10/20 8:10am - 9:15am65 mins
In Vivo Gene Therapy
Coffee Break & Exhibition Viewing Time
DAY THREE WATCH LIVE (EST); 21/10/20 8:10am - 9:15am65 mins
Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
Coffee Break & Exhibition Viewing Time
DAY THREE WATCH LIVE (EST); 21/10/20 9:15am - 9:25am10 mins
Cell Therapy
Chairperson’s Opening Remarks
- Anthony Davies, Ph.D. - Founder & CEO, Dark Horse Consulting
DAY THREE WATCH LIVE (EST); 21/10/20 9:15am - 9:25am10 mins
Gene Edited Ex Vivo Cell Therapy
Chairperson’s Opening Remarks
- Anthony Davies, Ph.D. - Founder & CEO, Dark Horse Consulting
DAY THREE WATCH LIVE (EST); 21/10/20 9:15am - 9:25am10 mins
In Vivo Gene Therapy
Chairperson’s Opening Remarks
- Anthony Davies, Ph.D. - Founder & CEO, Dark Horse Consulting
DAY THREE WATCH LIVE (EST); 21/10/20 9:15am - 9:25am10 mins
Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
Chairperson’s Opening Remarks
- Anthony Davies, Ph.D. - Founder & CEO, Dark Horse Consulting
DAY THREE WATCH LIVE (EST); 21/10/20 9:25am - 10:05am40 mins
Cell Therapy
State of the Industry
- Michael Lehmicke - Director, Science and Industry Affairs, Alliance for Regenerative Medicine
DAY THREE WATCH LIVE (EST); 21/10/20 9:25am - 10:05am40 mins
Gene Edited Ex Vivo Cell Therapy
State of the Industry
- Michael Lehmicke - Director, Science and Industry Affairs, Alliance for Regenerative Medicine
DAY THREE WATCH LIVE (EST); 21/10/20 9:25am - 10:05am40 mins
In Vivo Gene Therapy
State of the Industry
- Michael Lehmicke - Director, Science and Industry Affairs, Alliance for Regenerative Medicine
DAY THREE WATCH LIVE (EST); 21/10/20 9:25am - 10:05am40 mins
Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
State of the Industry
- Michael Lehmicke - Director, Science and Industry Affairs, Alliance for Regenerative Medicine
DAY THREE WATCH LIVE (EST); 21/10/20 10:05am - 10:55am50 mins
Cell Therapy
PANEL: Reimbursement Models for Novel Therapies
- Frank Zhang - Head of Market Access, uniQure
- Lisa Deschamps - SVP, Chief Business Officer, Novartis Gene Therapies
- Phillip D. Carter, Biopharma Executive
- Shefali Shah - Independent Consultant, Shefali Shah Consulting, LLC
- Sunil Karnawat - Vice President of Marketing & Sales, Ultragenyx Pharmaceutical
DAY THREE WATCH LIVE (EST); 21/10/20 10:05am - 10:55am50 mins
Gene Edited Ex Vivo Cell Therapy
PANEL: Reimbursement Models for Novel Therapies
- Frank Zhang - Head of Market Access, uniQure
- Lisa Deschamps - SVP, Chief Business Officer, Novartis Gene Therapies
- Phillip D. Carter, Biopharma Executive
- Shefali Shah - Independent Consultant, Shefali Shah Consulting, LLC
- Sunil Karnawat - Vice President of Marketing & Sales, Ultragenyx Pharmaceutical
DAY THREE WATCH LIVE (EST); 21/10/20 10:05am - 10:55am50 mins
In Vivo Gene Therapy
PANEL: Reimbursement Models for Novel Therapies
- Frank Zhang - Head of Market Access, uniQure
- Lisa Deschamps - SVP, Chief Business Officer, Novartis Gene Therapies
- Phillip D. Carter, Biopharma Executive
- Shefali Shah - Independent Consultant, Shefali Shah Consulting, LLC
- Sunil Karnawat - Vice President of Marketing & Sales, Ultragenyx Pharmaceutical
DAY THREE WATCH LIVE (EST); 21/10/20 10:05am - 10:55am50 mins
Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
PANEL: Reimbursement Models for Novel Therapies
- Frank Zhang - Head of Market Access, uniQure
- Lisa Deschamps - SVP, Chief Business Officer, Novartis Gene Therapies
- Phillip D. Carter, Biopharma Executive
- Shefali Shah - Independent Consultant, Shefali Shah Consulting, LLC
- Sunil Karnawat - Vice President of Marketing & Sales, Ultragenyx Pharmaceutical
DAY THREE WATCH LIVE (EST); 21/10/20 10:55am - 11:05am10 mins
Cell Therapy
Could we go paperless for cell therapy manufacturing? Vanderbilt adopts Chronicle software
- Scott Sobecki - Director, Research Informatics, Vanderbilt University Medical Center, USA
DAY THREE WATCH LIVE (EST); 21/10/20 10:55am - 11:05am10 mins
Gene Edited Ex Vivo Cell Therapy
Could we go paperless for cell therapy manufacturing? Vanderbilt adopts Chronicle software
- Scott Sobecki - Director, Research Informatics, Vanderbilt University Medical Center, USA
DAY THREE WATCH LIVE (EST); 21/10/20 10:55am - 11:05am10 mins
In Vivo Gene Therapy
Could we go paperless for cell therapy manufacturing? Vanderbilt adopts Chronicle software
- Scott Sobecki - Director, Research Informatics, Vanderbilt University Medical Center, USA
DAY THREE WATCH LIVE (EST); 21/10/20 10:55am - 11:05am10 mins
Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
Could we go paperless for cell therapy manufacturing? Vanderbilt adopts Chronicle software
- Scott Sobecki - Director, Research Informatics, Vanderbilt University Medical Center, USA
DAY THREE WATCH LIVE (EST); 21/10/20 11:05am - 11:15am10 mins
Cell Therapy
Chronicle Roundtable Discussion
- Per Hammer - Senior Product Manager, Cell & Gene Therapy Automation and Digital solutions, Cytiva, USA
- Scott Sobecki - Director, Research Informatics, Vanderbilt University Medical Center, USA
- Katie Golden - Laboratory Coordinator, Vanderbilt University Medical Center, USA
DAY THREE WATCH LIVE (EST); 21/10/20 11:05am - 11:15am10 mins
Gene Edited Ex Vivo Cell Therapy
Chronicle Roundtable Discussion
- Per Hammer - Senior Product Manager, Cell & Gene Therapy Automation and Digital solutions, Cytiva, USA
- Scott Sobecki - Director, Research Informatics, Vanderbilt University Medical Center, USA
- Katie Golden - Laboratory Coordinator, Vanderbilt University Medical Center, USA
DAY THREE WATCH LIVE (EST); 21/10/20 11:05am - 11:15am10 mins
In Vivo Gene Therapy
Chronicle Roundtable Discussion
- Per Hammer - Senior Product Manager, Cell & Gene Therapy Automation and Digital solutions, Cytiva, USA
- Scott Sobecki - Director, Research Informatics, Vanderbilt University Medical Center, USA
- Katie Golden - Laboratory Coordinator, Vanderbilt University Medical Center, USA
DAY THREE WATCH LIVE (EST); 21/10/20 11:05am - 11:15am10 mins
Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
Chronicle Roundtable Discussion
- Per Hammer - Senior Product Manager, Cell & Gene Therapy Automation and Digital solutions, Cytiva, USA
- Scott Sobecki - Director, Research Informatics, Vanderbilt University Medical Center, USA
- Katie Golden - Laboratory Coordinator, Vanderbilt University Medical Center, USA
DAY THREE WATCH LIVE (EST); 21/10/20 11:15am - 11:25am10 mins
Cell Therapy
Q&A
DAY THREE WATCH LIVE (EST); 21/10/20 11:15am - 11:25am10 mins
Gene Edited Ex Vivo Cell Therapy
Q&A
DAY THREE WATCH LIVE (EST); 21/10/20 11:15am - 11:25am10 mins
In Vivo Gene Therapy
Q&A
DAY THREE WATCH LIVE (EST); 21/10/20 11:15am - 11:25am10 mins
Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
Q&A
DAY THREE WATCH LIVE (EST); 21/10/20 11:25am - 11:50am25 mins
Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
Novel Bioreactor System for Fabrication of Musculoskeletal Tissues
- Lisa Larkin - Professor, Molecular & Integrative Physiology Professor, Biomedical Engineering, University of Michigan, USA
DAY THREE WATCH LIVE (EST); 21/10/20 11:30am - 11:50am20 mins
Cell Therapy
Augmenting Automated Analytics for Cell & Gene Therapy Manufacture
- Veeren Chauhan - Nottingham Research Fellow in Bio-inspired Therapeutics in the Advanced Materials & Healthcare Technologies, University of Nottingham
DAY THREE WATCH LIVE (EST); 21/10/20 11:30am - 11:50am20 mins
Gene Edited Ex Vivo Cell Therapy
Product Dependent Cryopreservation Protocols
- David McKenna - Professor and American Red Cross Chair in Transfusion Medicine, Department of Laboratory Medicine and Pathology, University of Minnesota
DAY THREE WATCH LIVE (EST); 21/10/20 11:30am - 11:50am20 mins
In Vivo Gene Therapy
Emerging upstream bioprocessing and analytical tools for vector manufacture
- Michael J. DiBiasio-White, Sr. - Sr. Scientist: BioProcess Development/Protein Sciences, Ring Therapeutics
DAY THREE WATCH LIVE (EST); 21/10/20 11:50am - 12:15pm25 mins
Cell Therapy
Speaker Q&A - Cell Therapy Analytics – Testing, Characterization & Validation Strategies
- Michael Roberts - Chief Technology Officer (Europe), Asklepios BioPharmaceutical, Inc.
- Qin Zou, Ph.D. - Associate Research Fellow and Group Leader, Pfizer
- Jennifer L. Dashnau - Head of Analytical Development and Quality Control, Century Therapeutics, USA
DAY THREE WATCH LIVE (EST); 21/10/20 11:50am - 12:15pm25 mins
Gene Edited Ex Vivo Cell Therapy
Speaker Q&A - Cryopreservation & Vein-to-vein and Downstream Considerations
- Donald Singer - Consultant, formerly, GSK Senior Fellow, Microbiology, Biopharmaceutical GMP Operations, USA
- Jason Acker - Professor, Laboratory Medicine and Pathology, University of Alberta, Canada
- David McKenna - Professor and American Red Cross Chair in Transfusion Medicine, Department of Laboratory Medicine and Pathology, University of Minnesota
- Sarah Nikiforow - Asst. Professor, Stem Cell Transplantation Program, Asst. Medical Director, Cell Manipulation Core Facility, Dana-Farber Cancer Institute
DAY THREE WATCH LIVE (EST); 21/10/20 11:50am - 12:15pm25 mins
In Vivo Gene Therapy
Speaker Q&A - Gene Therapy Analytics
- Franz Schnetzinger - Director Analytical Development, Gyroscope Therapeutics
- David Dobnik - Scientific Associate, National Institute of Biology, Slovenia
- Michael J. DiBiasio-White, Sr. - Sr. Scientist: BioProcess Development/Protein Sciences, Ring Therapeutics
DAY THREE WATCH LIVE (EST); 21/10/20 11:50am - 12:10pm20 mins
Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
Microscale Sensors and Systems for Tissue Engineering and Organs on a Chip Applications
- Mehmet Dokmeci - Adjunct Professors, University of California (UCLA)
DAY THREE WATCH LIVE (EST); 21/10/20 12:10pm - 12:55pm45 mins
Cell Therapy
Exhibition Viewing Time & Live Labs
DAY THREE WATCH LIVE (EST); 21/10/20 12:10pm - 12:55pm45 mins
Gene Edited Ex Vivo Cell Therapy
Exhibition Viewing Time & Live Labs
DAY THREE WATCH LIVE (EST); 21/10/20 12:10pm - 12:55pm45 mins
In Vivo Gene Therapy
Exhibition Viewing Time & Live Labs
DAY THREE WATCH LIVE (EST); 21/10/20 12:10pm - 12:55pm45 mins
Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
Exhibition Viewing Time & Live Labs
Get the latest news.
As it happens
Sign up to get the latest on the agenda and speakers.
Choose Day
- WATCH ON DEMAND: Industry PresentationsWATCH ON DEMAND: Industry Presentations
- DAY ONE WATCH LIVE (EST); 19/10/20DAY ONE WATCH LIVE (EST); 19/10/20
- DAY TWO WATCH LIVE (EST); 20/10/20DAY TWO WATCH LIVE (EST); 20/10/20
- DAY THREE WATCH LIVE (EST); 21/10/20DAY THREE WATCH LIVE (EST); 21/10/20
- DAY FOUR WATCH LIVE (EST); 22/10/20DAY FOUR WATCH LIVE (EST); 22/10/20
- WATCH ON DEMAND: Spotlight PresentationsWATCH ON DEMAND: Spotlight Presentations
- Download Agenda